Origin
A graduate of NYU and the University at Buffalo School of Medicine, David Dantzker pursued an academic career, becoming Professor of Medicine at the Universities of Michigan and Texas and at Albert Einstein College before being appointed Chairman of the American Board of Internal Medicine. After serving as CEO of the second-largest hospital group in the US, he spent fifteen years in medical investing. He joined the Board of Origin in 2012 and accepted the position of Chief Medical Officer the following year.
This person is not in any offices
Origin
Origin is a privately-held, clinical-stage biotechnology company founded in June 2010 to develop and commercialize a novel, patented medical technology - delivering therapeutic molecules generated right at the point of care.